Dengue Virus (DV) Enhancing Antibody Activity in Preillness Plasma Does Not Predict Subsequent Disease Severity or Viremia in Secondary DV Infection
Kamolwish Laoprasopwattana(University of Massachusetts Chan Medical School), Sharone Green(University of Massachusetts Chan Medical School), David W. Vaughn(Armed Forces Research Institute of Medical Science), George Reed, Daniel H. Libraty(Unknown), Ananda Nisalak(Armed Forces Research Institute of Medical Science), Timothy P. Endy(Walter Reed Army Institute of Research), Supamit Chunsuttiwat(Ministry of Public Health), Francis A. Ennis(University of Massachusetts Chan Medical School), Alan L. Rothman(University of Rhode Island)
Cited by 106
Related Papers
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
|New England Journal of Medicine|2009|3k
Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms
|Nature reviews. Immunology|2011|762
Neurological manifestations of dengue infection
|The Lancet|2000|637